Company intelligence / Profile preview

Oncovision

Ownership: Private
Development stage: Commercial

Overview

Oncovision has commercialized several innovative medical imaging products based on nuclear medicine techniques. Their portfolio includes the Sentinella gamma camera for intraoperative use, Mammi PET for breast cancer diagnostics, Wprobe gamma probe for radioguided surgery, and CareMiBrain dedicated brain PET scanner. These products are used globally in over thirty markets to improve early detection of cancer and neurological diseases such as Alzheimer’s.

Therapeutic areas: OncologyNeurology
Modalities: DeviceRadiopharmaceutical (for nuclear medicine imaging)PET imaging device (Positron Emission Tomography)Gamma camera device (for intraoperative and diagnostic use)
Industry: Medical Imaging

Partnerships

Capitalized by Innvierte investment program of CDTI E.P.E.supported by Generalitat Valenciana through Fondos Plan Resistir Plus

Beyond the preview

Go deeper on Oncovision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncovision.

Explore the full profile